EQS-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Strategic Company Decision Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and ...

Takeda Pharmaceutical Company ( ($TAK) ) has provided an announcement. In November 2025, Takeda Pharmaceutical Company announced significant ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

Takeda Pharmaceutical offers attractive dividends and has a low price/book ratio, making it appealing despite recent price drops and US policy uncertainties. The company reported strong Q3 earnings, ...

AC Immune SA's Takeda Pharmaceutical Company partnership brought in an upfront payment of $100 million, with the potential to earn up to $2.1 billion in milestone payments. Interim safety and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In this episode of PNC C-Speak, Christophe Weber, president ...

We recently compiled a list of the 10 Best Japanese Stocks To Buy Now. In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other ...

On Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited (NYSE:TAK) announced a restructuring after the company reported a fiscal year 2023 net profit of 144 billion yen (around $954 ...

The companies will jointly develop IBI363 on a global scale and co-commercialise the therapy in the US.

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.